Contra Acer Therapeutics
13F holders, Q1 2024 (March 31)1holders
$0.00avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Contra Acer Therapeutics in their 13F filings. The largest holder was Thompson Investment Management, Inc. ($0).
- Company
- Contra Acer Therapeutics
- CUSIP
- 004CVR049
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| Thompson Investment Management, Inc. | 0.00% | No change | 10 | $0 |
"% of holder's portfolio" is CONTRA ACER THERAPEUTICS's weight in each manager's 13F, not the share of Contra Acer Therapeutics the manager owns.